Hosted on MSN2mon
Kronos Bio announces interim CEO and workforce cuts of 83%Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective from 3 December 2024. Dr Knobelman will also become principal executive ...
Hosted on MSN2mon
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-UpShares of cancer therapy developer Kronos Bio Inc. ($KRON) surged over 13% to hit their highest level since Nov. 6, with trading volume spiking more than six times ...
Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul Kronos Bio announces major leadership changes and an 83% workforce reduction as part of a strategic overhaul ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback